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Review
Introduction: Molecules, Networks, 
and Behavior
Neuroscience aims to elucidate the neural underpinnings 
of perception, cognition, and adaptive behavior. Neural 
functioning and plasticity can be studied on different lev-
els of organization and complexity ranging from the 
molecular and synaptic level to neural circuitry of whole 
brain networks. Across neuroscience, different methods 
are being applied to better understand the role of different 
brain regions, networks, and neurotransmitter systems in 
the evolution of higher brain functions.
γ-Amino-butyric acid (GABA) is the main inhibitory 
neurotransmitter in the adult mammalian brain, formed by 
the decarboxylation of glutamate, an enzyme-driven process 
that primarily takes place in GABAergic interneurons. This 
synthesis is associated with two different isoforms of the 
glutamic acid decarboxylase (GAD), GAD65 und GAD67. 
Both isoforms can be found in most GABAergic neurons. 
Whereas GAD67 is distributed throughout the cell cyto-
plasm, GAD65 is highly concentrated in nerve endings, as 
such GAD65 is critically involved in GABA synthesis tar-
geting vesicular release (Soghomonian and Martin 1998). 
GABA either binds to GABAA receptors, which are chloride 
permeable pentameric channels, eliciting a chloride influx 
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Abstract
Neural functioning and plasticity can be studied on different levels of organization and complexity ranging from the 
molecular and synaptic level to neural circuitry of whole brain networks. Across neuroscience different methods 
are being applied to better understand the role of various neurotransmitter systems in the evolution of perception 
and cognition. GABA is the main inhibitory neurotransmitter in the adult mammalian brain and, depending on the 
brain region, up to 25% of the total number of cortical neurons are GABAergic interneurons. At the one end of the 
spectrum, GABAergic neurons have been accurately described with regard to cell morphological, molecular, and 
electrophysiological properties; at the other end researchers try to link GABA concentrations in specific brain regions 
to human behavior using magnetic resonance spectroscopy. One of the main challenges of modern neuroscience 
currently is to integrate knowledge from highly specialized subfields at distinct biological scales into a coherent picture 
that bridges the gap between molecules and behavior. In the current review, recent findings from different fields of 
GABA research are summarized delineating a potential strategy to develop a more holistic picture of the function and 
role of GABA.
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and subsequent hyperpolarization in mature cells (in healthy 
condition) (Kaila and others 2014), or to GABAB receptors, 
which are G-protein coupled receptors interacting with 
potassium and calcium channels. This interaction either elic-
its a postsynaptic potassium efflux inducing a slow inhibi-
tory potential or inhibits presynaptic calcium channels 
leading to a suppression of neurotransmitter release (Ulrich 
and Bettler 2007).
GABAergic interneurons are diverse. Present-day 
classification systems predominantly use morphological, 
electrophysiological, and neurochemical properties to 
determine specific subtypes. About 20 cortical and 20 
hippocampal subtypes have been identified so far. Forty 
percent of cortical interneurons have fast-spiking (FS) 
electrophysiological properties; that is, basket and chan-
delier cells and express the cytoplasmic calcium-binding 
protein (CaBP) parvalbumin (PV); about 30% of the cor-
tical interneurons express the neuropeptide somatostatin, 
for example, Martinotti cells, and about 30% express the 
serotonin receptor 3A, for example, vasointestinal pep-
tide (VIP) expressing cells, calretinin (CR) expressing, 
fast adapting cells and reelin expressing, late-spiking 
cells. Calbindin (CB), another CaBP, is expressed in a 
variety of GABAergic cells, but is considered an inaccu-
rate classification marker. Importantly, current classifica-
tion systems are viewed as “work in progress” by most 
researches, and further modifications are warranted. Of 
note, the majority of studies on GABAergic cells exclu-
sively focuses on interneurons; however, there are long-
range GABAergic neurons that, for example, reciprocally 
connect the entorhinal cortex (EC) and the hippocampus 
(Caputi and others 2013).
During early development, GABAergic and glutama-
tergic progenitor cells follow different paths to reach their 
destination. GABAergic interneurons are produced in the 
ventral telencephalon and migrate tangentially into the 
neocortex, whereas glutamatergic excitatory neurons are 
generated in the ventricular zone of the dorsal telenceph-
alon and migrate radially into the cortical plate (Sultan 
and others 2013). Depending on the brain region, 
GABAergic interneurons constitute 10% to 25% of the 
total number of cortical neurons. During maturation the 
expression and functioning of various receptors, for 
example, NMDA and AMPA receptors, as well as ion 
channels change several times.
As GABAergic transmission matures, interneurons 
start to act as circuit pacemakers. Especially FS interneu-
rons seem to play a critical role in synchronizing network 
activity, enabling oscillations in different frequency bands, 
for example, the generation of gamma rhythms (Le 
Magueresse and Monyer 2013). These rhythms and tran-
sient changes thereof are of great interest to the under-
standing of various cognitive processes. As such sharp 
wave-associated ripple oscillations in the hippocampus 
are thought to emerge from pacing of pyramidal cells by 
PV+, FS basket cells; the development of theta activity, 
the major hippocampal rhythm during exploration, also 
seems to be strongly modulated by GABAergic interneu-
rons. In humans, gamma activity as well as alpha activity 
have been linked to cortical information processing 
(Lozano-Soldevilla and others 2014); furthermore, dys-
functional gamma oscillations, for example, in the pre-
frontal cortex, seem to reflect working memory deficits, 
for instance, in patients with schizophrenia (Senkowski 
and Gallinat 2015). At the systems level, a number of elec-
troencephalography (EEG) and magnetoencephalography 
(MEG) studies, as well as computational modeling, sug-
gest that the GABAergic system plays a pivotal role in 
synchronizing larger neural cell populations. However, 
the relationship between oscillations and behavior remains 
to be fully elucidated.
Overall, there is a well-established and steadily 
increasing knowledge about the development, the onset 
of functioning, the subtypes, the electrophysiological 
properties and the target cells of GABAergic neurons (Le 
Magueresse and Monyer 2013). In the long run, however, 
findings from basic neuroscience need to be interpreted 
in the light of behavior (in health and disease). In the cur-
rent review article, we summarize recent developments in 
GABA neuroscience, relating evidence from different 
levels of neural organization and complexity to behavior 
in both animals and humans.
Inhibition in the  
Hippocampal-Entorhinal Formation
The hippocampal-entorhinal formation is essential for the 
formation of spatial and episodic memories, assembling 
what happened, when and where (Knierim and others 
2014). Specifically, the role of the hippocampus for spatial 
learning and memory is well established. Moreover, selec-
tive genetic manipulations in the forebrain or only in the 
hippocampus, revealed the significance of inhibitory 
GABAergic neurons, in particular PV+, FS interneurons, 
for oscillatory network activities, spatial coding, and hip-
pocampus-dependent working memory (Caputi and oth-
ers 2012; Fuchs and others 2007). The entorhinal cortex 
(EC) is a major input structure to the hippocampus. The 
superficial layer II and layer III of the EC are the origin of 
the perforant path terminating in the dentate gyrus and the 
temporo-ammonic pathway terminating in the CA1 region 
of the hippocampus. However, if and how the EC partici-
pates in information processing and episodic memory for-
mation is still a matter of debate. In rodents, the EC can be 
divided into two subdivisions, the medial EC (MEC) and 
the lateral EC (LEC). Of note, the two subdivisions of the 
EC are postulated to be part of two parallel input streams: 
the spatial stream provides spatial or “where” information 
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through the MEC, and the nonspatial stream provides fea-
ture or “what” information through the LEC, to the hip-
pocampus (Knierim and others 2014) (Fig. 1A).
The wealth of information regarding inhibitory inter-
neurons in the hippocampus is in stark contrast to the rela-
tively scarce knowledge about interneurons and their 
function in the MEC, and even more so in the LEC. The 
MEC receives information from spatial input areas and 
during tetrode recordings in freely behaving rodents, neu-
rons in the superficial layers of the MEC exhibit spatial-
selective firing patterns. In vivo tetrode recordings in freely 
behaving animals are used to measure extracellularly field 
potentials from neuronal populations and spatially modu-
lated firing of single neurons. The recorded action poten-
tials from individual neurons, that is, spikes, differ in 
waveform and firing rate, which can be used to distinguish 
between spikes originating from FS inhibitory neurons and 
putative excitatory neurons (Buetfering and others 2014).
The best-studied examples are grid cells, which display 
multiple firing fields forming a hexagonal pattern in a two-
dimensional environment (Hafting and others 2005). 
Recent experimental data highlight the role of inhibition for 
the formation of the particular firing pattern of grid cells. 
This notion is based on in vitro patch-clamp recordings of 
paired neurons demonstrating that putative grid cells, the 
so-called excitatory stellate cells in layer II of the MEC, do 
not communicate with each other, which is supported by in 
vivo recordings in freely behaving mice. However, these 
experiments showed that stellate cells are indirectly con-
nected via FS interneurons (Couey and others 2013; Fuchs 
and others 2016). Notably, immunohistological experi-
ments revealed that about half of all GABAergic neurons in 
layer II of the MEC are PV+, FS interneurons (Buetfering 
and others 2014). Interestingly, FS interneurons seem to be 
more broadly tuned as compared with spatial-selective grid 
cells (Buetfering and others 2014). Moreover, excitatory 
neurons in layer II of the MEC express either the CaBP CB 
or the extracellular matrix protein reelin. When taken elec-
trophysiological and anatomical features into account, these 
two excitatory cell populations can be further subdivided 
into four distinct cell types that exhibit cell-type-specific 
local excitatory and inhibitory connectivity (Fuchs and oth-
ers 2016) (Fig. 1B).
The LEC receives information from nonspatial input 
areas, that is, the perirhinal cortex and the olfactory bulb. 
Neurons in the LEC exhibit only sparse spatial selectivity 
although they respond to objects, the position of objects 
or odors (Knierim and others 2014; Leitner and others 
2016), thereby encoding the “what” component of epi-
sodic memories. Little is known about the functional role 
or the connectivity of inhibitory neurons in the LEC. Of 
note, a recent study showed that also in the LEC 
GABAergic neurons are more broadly tuned to odors as 
compared with distinct populations of excitatory neurons 
in layer II of the LEC (Leitner and others 2016).
Finally, GABAergic neurons are critically involved in 
oscillatory network activities that may underlie numerous 
cognitive functions (Fuchs and others 2007). Supporting 
evidence for a crucial role of inhibitory neurons in shap-
ing network activities are recent findings demonstrating 
that functionally related brain regions are often connected 
via reciprocal long-range inhibitory projections. Since 
the medial septum is considered the major pacemaker for 
rhythmic network activities in the hippocampal-entorhi-
nal formation (Buzsáki 2002), the reciprocal inhibitory 
connectivity between the medial septum and the hippo-
campus (Freund and Antal 1988) and between the medial 
septum and the MEC (Fuchs and others 2016) are of spe-
cial interest for hippocampal-entorhinal network activi-
ties. Moreover, long-range GABAergic neurons connect 
the MEC and the hippocampus (Melzer and others 2012), 
and the LEC and the hippocampus (Basu and others 
2016). This long-range inhibitory connectivity between 
the medial septum, the hippocampus and the entorhinal 
subregions could orchestrate oscillatory activity and 
thereby support episodic memory formation.
Modulation of Cortical GABAergic 
Inhibition by Noninvasive Brain 
Stimulation
Functional assessment of GABAergic neurotransmission at 
high temporal and spatial resolution is required to learn 
more about the role of cortical inhibition in higher brain 
Figure 1. Local and long-range connectivity of inhibitory 
PV+, FS neurons in layer II of the MEC. (A) Scheme 
depicting the hippocampal-entorhinal formation in a rodent 
horizontal brain section (right). Boxed area shown at a higher 
magnification: input from LII of the MEC provides spatial 
“where” information, input from LII of the LEC provides 
feature or “what” information to the hippocampus (left). 
(B) Inhibitory (blue) FS interneuron in MEC LII receives 
inhibition via long-range GABAergic projection from the MS, 
and communicate locally with excitatory (red) SC, IMSC, 
and IMPC, but not PC in LII of the MEC. HC, hippocampus; 
MEC, medial entorhinal cortex; LEC, intermediate entorhinal 
cortex; L, layer; FS, fast-spiking neuron; SC, stellate cell; 
IMSC, intermediate stellate cell; PC, pyramidal cell; IMPC, 
intermediate pyramidal cell; MS, medial septum.
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functions. In this context, noninvasive brain stimulation, 
specifically transcranial magnetic stimulation (TMS), has 
been successfully employed to assess the role of GABAergic 
inhibition in both animals and humans. Based on the physi-
cal principle of electromagnetic induction TMS allows for 
the activation of cortical neurons through the intact skin and 
skull. Repetitive TMS (rTMS), that is, the application of 
several hundred TMS pulses, is known to modulate cortical 
excitability even beyond the stimulation period (depending 
on the frequency and the pattern of stimulus trains). While 
several hundred pulses at 1 Hz reduce cortical excitability, 
frequencies of 5 Hz and above enhance it. A variety of pro-
tocols has been established in the field, including patterned 
stimulation protocols, for example, continuous and inter-
mittent theta burst stimulation (cTBS and iTBS, respec-
tively; Huang and others 2005).
However, the cellular and molecular mechanisms of 
rTMS-induced changes of cortical excitability, and conse-
quently the neurobiology of rTMS-based therapies are not 
well understood (Cirillo and others 2017; Müller-Dahlhaus 
and Vlachos 2013; Pell and others 2011). The transient 
nature of rTMS-induced changes in motor evoked poten-
tials (MEPs; lasting for several minutes to hours), and the 
fact that rTMS is neither context- nor input-specific makes 
it unlikely that associative plasticity of selective neural 
pathways and circuits, that is, long-term potentiation 
(LTP) and long-term depression (LTD) of excitatory post-
synapses, underlies lasting TMS effects. Rather, changes 
in the cortical balance of excitation and inhibition may 
enable subsequent plastic changes of the network via “gat-
ing” and “metaplasticity” (Müller-Dahlhaus and Ziemann 
2015; Ziemann and Siebner 2008).
Animal studies have shown that rTMS is able to affect 
distinct cortical inhibitory systems depending on the 
stimulation pattern employed (Fig. 2A), and that these 
effects interfere with sensory processing and learning 
(Mix and others 2010; Reis and others 2008; Thimm and 
Funke 2015). It turns out that iTBS most efficiently 
induces a strong reduction in the expression of PV+, FS 
interneurons, while cTBS and low-frequency (1 Hz) 
rTMS preferentially reduce the expression of CB, another 
CaBP found in non-FS interneurons (Markram and others 
2004). CR+ interneurons which appear to preferentially 
target other interneuron populations (eg, the PV+ and 
CB+), were not affected by any stimulation protocol 
tested so far (Benali and others 2011) (Fig. 2B).
Rodent work has shown that only one block of iTBS 
(600 pulses within 192 seconds) induces a decline in PV, 
GAD67 and CB expression starting about 30 minutes 
after the stimulation and slowly recovering within 160 
minutes (Hoppenrath and Funke 2013). However, a stron-
ger reduction in PV expression obtained with five blocks 
of iTBS (at 15-minute intervals; Volz and others 2013) 
can also last for days while the decrease in CB caused by 
five cTBS blocks recovers more rapidly (Benali and oth-
ers 2011). Early after iTBS (10-20 minutes) the immedi-
ate early gene product c-Fos and presynaptic GAD65 
show enhanced expression, indicating that iTBS increases 
neuronal activity including that of GABAergic neurons 
(Fig. 3B, right panels). Apparently, distinct stimulation 
protocols can modulate the activity of different classes of 
GABAergic interneurons, with iTBS affecting the activ-
ity of FS interneurons that control pyramidal cell output 
activity via perisomatic inhibition, and 1 Hz and cTBS 
affecting the activity of non-FS (CB+) interneurons con-
trolling the dendritic input to pyramidal neurons. Notably, 
these distinct interneuron populations and changes in the 
respective CaBPs (in part due to reduced interneuron cell 
number) are thought to be involved in the pathophysiol-
ogy of psychiatric and neurological diseases such as 
schizophrenia and epilepsy (Lewis and others 2005).
The consequences of rTMS-induced modulation of 
GABAergic neurotransmission and its effect on percep-
tion and cognition remain to be fully elucidated. Recent 
basic science work employing optogenetic approaches has 
provided new insights into the functional role of inhibition 
for complex brain function (Letzkus and others 2011). 
These studies confirm previous work that discloses a rel-
evance of disinhibition, that is, a transient reduction in 
cortical inhibition, in learning and memory formation. 
Hence, it is conceivable that rTMS modulates the ability 
of distinct cortical regions to express input- and context-
specific plasticity by transiently changing local cortical 
GABAergic neurotransmission. Indeed, electrophysiolog-
ical recordings of evoked sensory activity from the rat bar-
rel cortex reveal a disinhibitory effect of iTBS, which was 
most prominent for the late intracortically mediated 
response components known to be relevant for the percep-
tion of stimuli (Thimm and Funke 2015) (Fig. 3).
Follow-up histology revealed a decrease in GAD67 
and PV (but not CB) and increased c-Fos expression. No 
such prominent effect was found with cTBS, which 
decreased the CB and c-Fos expression but not that of PV. 
Another study revealed that iTBS, but not cTBS, improved 
the rat’s ability to learn a pure tactile orientation task (Mix 
and others 2010). Rats treated with iTBS shortly before 
each task block showed about a 50% increase in learning 
speed compared to sham treated animals (Fig. 4).
Interestingly, PV showed a bidirectional change in 
expression depending on the combination of iTBS and 
learning. Animals treated with iTBS but not performing 
the task (put back to standard cage) showed the typical, 
about 50% reduction in PV+ cells in frontal, parietal, and 
occipital cortical areas. However, those rats completing 
the task showed significantly less reduction in PV expres-
sion in those cortical areas expected to be involved in the 
task (barrel, motor, and frontal cortex) but not in the 
visual cortex being not essential for the task.
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These findings support the notion that modulation of 
inhibition is a key mechanism to control neuronal plastic-
ity and the ability to learn (Letzkus and others 2015), that 
changed expression of PV is a sign of plasticity of FS 
interneurons in the course of learning (Donato and others 
2013) and that non-invasive brain stimulation can be used 
to affect these processes.
Finally, in a recent study using 10 Hz repetitive mag-
netic stimulation of slice culture preparations direct 
experimental evidence was provided that repetitive 
magnetic stimulation reduces inhibitory neurotransmis-
sion in a Ca2+ dependent manner, which requires the 
activation of NMDARs and L-type voltage-gated cal-
cium channel. Interestingly, dendritic but not somatic 
inhibition was affected 2 to 4 hours after stimulation. 
This observation adds an additional postsynaptic level 
of complexity, demonstrating that not only specific 
inhibitory interneurons are affected but also selected 
inhibitory postsynapses are modulated in response to 
repetitive magnetic stimulation (Lenz and others 2016; 
Lenz and Vlachos 2016).
Together, these studies demonstrate that rTMS is a 
powerful tool for modulation of cortical excitability 
through changes in inhibitory networks. It is interesting 
to speculate that the therapeutic effects of rTMS may in 
part underlie network disinhibition, which could improve 
or restore the ability of stimulated networks to express 
endogenous context-specific plasticity.
Figure 2. Modulation of the expression of activity markers of inhibitory cortical systems in a rat repetitive transcranial magnetic 
stimulation (rTMS) model. (A) rTMS was applied via a figure-8 shaped coil (2 × 70 mm) directed in a way to induce a mediolateral 
oriented electric field within the rat brain (left, red arrow) suitable to stimulate callosal axons (middle), thereby activating layer 
2/3 pyramidal cells and interneurons (right). (B) Changes in the cortical (here motor cortex data shown) expression of the 
calcium-binding proteins parvalbumin (PV), calbindin (CB), and calretinin (CR) induced by either 1 Hz rTMS (1200 pulses in one 
train), intermittent theta burst stimulation (iTBS; bursts of 3 pulses at 50 Hz, repeated at 5 Hz with 2-second ON and 8-second 
OFF periodicity, 5 block of 600 pulses each) or continuous TBS (cTBS; single 40-second train of bursts in a block) compared with 
sham stimulation (left). iTBS strongly reduced PV expression, which could last several days without further interference (lower 
left). Expression of c-Fos and GAD65 were strongly increased immediately after one iTBS block while PV decreased after about 
40 minutes (lower middle and right). *P < .05, **P < .01, ***P < .001. Part B of the figure has been redrawn using data of Benali 
and others (2011) and Hoppenrath and Funke (2013).
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Noninvasive Brain Stimulation: A 
Tool to Assess Cortical GABAergic 
Neurotransmission in Humans
In line with stimulation protocols used in animal research, 
cortical GABAergic inhibition can be measured in 
humans using paired-pulse TMS. For example, short-
interval SICI is determined by applying two consecutive 
TMS pulses at short interstimulus intervals (ISIs) of 1 to 
5 ms, with the first conditioning pulse being subthreshold 
(i.e., not evoking an MEP), but suppressing the MEP 
induced by the second suprathreshold TMS pulse (Kujirai 
and others 1993). The ratio of the amplitudes of the con-
ditioned and the unconditioned MEP gives a quantifica-
tion of the inhibition induced by the conditioning pulse, 
that is short-interval intracortical inhibition (SICI). In 
contrast, long-interval intracortical inhibition (LICI) 
involves the application of two suprathreshold TMS 
pulses at longer ISIs of 50 to 200 ms; here the first condi-
tioning pulse likewise suppresses the MEP evoked by the 
second test pulse (Valls-Sole and others 1992). 
Pharmacological studies indicated that SICI reflects syn-
aptic GABAA receptor dependent inhibition, while LICI 
reflects activation of metabotropic GABAB receptors 
(McDonnell and others 2006; Ziemann and others 1996; 
Ziemann and others 2015). Hence, TMS can be used to 
determine GABAergic inhibition in the intact human 
motor cortex noninvasively, and relate level and changes 
in GABAergic neurotransmission to complex brain func-
tions. This approach has been extensively used in clinical 
neuroscience in recent years and has provided important 
insights into the pathophysiological role of GABAergic 
inhibition in neurological and psychiatric diseases 
(Berardelli and others 2008; Bunse and others 2014).
However, TMS as a stand-alone technique has only 
limited capacity to gain insights into higher brain func-
tions. This potential can be significantly enhanced by 
combining TMS with simultaneous measurements of cor-
tical activity in other electrophysiological or imaging 
modalities (Ziemann 2011). Registration of electroen-
cephalography during TMS (TMS-EEG) is an interesting 
tool, which allows to measure TMS effects also in non-
motor brain areas with high temporal and reasonable spa-
tial resolution. Importantly, the development of 
TMS-compatible EEG amplifiers renders it possible to 
register TMS-evoked neural excitation at EEG electrodes 
overlying the stimulation site shortly (<10 ms) after the 
TMS pulse, and to record its propagation throughout 
large-scale brain networks for hundreds of milliseconds 
(Ilmoniemi and others 1997). As the EEG signal is mainly 
generated by excitatory and inhibitory postsynaptic cur-
rents TMS-EEG offers a unique window to noninvasively 
measure the excitation-inhibition balance in the intact 
human brain.
Pharmacological studies have shown that an early 
negative deflection of the TMS-evoked EEG response 
at around 45 ms after a TMS pulse (N45) reflects 
GABAA receptor–mediated synaptic inhibition, as it is 
enhanced by the GABAA receptor agonists alprazolam, 
diazepam and zolpidem (Fig. 5A and B), whereas a 
later negative potential at around 100 ms after the TMS 
pulse (N100) most likely reflects GABAB receptor 
mediated synaptic inhibition, as it is enhanced by the 
GABAB receptor agonist baclofen (Premoli and others 
2014) (Fig. 5B).
The potential of these noninvasive markers of cortical 
GABAergic inhibition for clinical practice is exemplified 
by one recent study, which showed that the measurement 
of the N100 in the dorsolateral prefrontal cortex can offer 
prognostic value for therapeutic interventions in patients 
with treatment-resistant major depression (Sun and oth-
ers 2016). In addition, recent work suggests that TMS-
evoked EEG potentials may also reflect activity of 
extrasynaptic GABAAα5 receptors (Darmani and others 
2016) (Fig. 5C), which mediate tonic inhibition and may 
play a crucial role in functional recovery poststroke 
(Clarkson and others 2010).
Together, these findings disclose that TMS is a prom-
ising tool to assess the functional role of GABAergic neu-
rotransmission in human behavior and may help define 
measures of GABA with diagnostic and prognostic value 
in patients with neurological and psychiatric diseases.
Figure 3. Increased cortical sensory responsiveness after 
intermittent theta burst stimulation (iTBS). With each of the 5 
blocks applied (600p/block) iTBS increased sensory responses 
to whisker deflections (800 deg/s, 1.72 deg) in rat barrel 
cortex while continuous TBS (cTBS) had no significant effect. 
Especially late sensory response components suggested to be 
under control of recurrent inhibition are affected. Shown are 
peristimulus time histograms of single-/multi-unit recordings 
with responses obtained during sham-stimulation experiments 
in blue, verum iTBS in red, and verum cTBS in green. 
Responses to 30 identical stimulus repetitions were averaged. 
Modified from Thimm and Funke (2015).
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Measuring GABA In Vivo With 
Magnetic Resonance Spectroscopy
GABA can be measured in vivo using magnetic resonance 
spectroscopy (MRS). This MRS measure of GABA is 
thought to reflect bulk GABA from a large region of inter-
est, and is thought to predominantly reflect cellular, rather 
than synaptic GABA levels (Rae 2014; Stagg 2014). 
Functionally, GABA levels are thought to reflect the extent 
to which a region of interest can exert inhibition (Rae 2014). 
On this macro level, studies have shown that GABA is 
associated with brain function as measured with multi-
modal neuroimaging techniques (Duncan and others 2014). 
Given the relationship between GABA and brain function, 
a large number of studies have set out to investigate whether 
GABA levels, as measured with MRS, are associated with 
cognitive function in both health and disease.
The in vivo concentration of GABA (1-2 mM) places 
it at the lower end of the detectable range for MRS. The 
limited chemical shift separation of 1H-MRS gives an in 
vivo spectrum where individual signals highly over-
lapped, and therefore three main approaches are used to 
reduce signal overlap and detect GABA (Puts and Edden 
2012): ultra-high-field MRS (at fields of 7 T and above); 
two-dimensional (usually J-resolved) MRS; and edited 
MRS. Of these, edited MRS is the most widely used 
approach, perhaps largely due to ease of implementation 
(Mullins and others 2014). Editing the MRS spectrum 
amounts to reducing the number of signals in the MR 
spectrum to reduce signal overlap and improve resolution 
of the GABA signals (Rothman and others 1993).
It is possible to design an edited experiment specifi-
cally to reveal GABA signals from underneath larger 
overlapping signals from more concentrated metabolites. 
J-difference editing involves acquiring two subexperi-
ments that differ in their treatment of the GABA signals, 
but which treat creatine signals at 3 ppm the same. Thus, 
the difference spectrum, calculated by subtracting the 
results of the two subexperiments, has the creatine signals 
removed and the GABA signal revealed. In order to edit 
GABA, frequency-selective editing pulses are applied to 
GABA signals at 1.9 ppm to manipulate evolution of the 
GABA signal at 3 ppm, which is detected in the differ-
ence spectrum (Fig. 6A).
Because of the limited sensitivity of MRS and the low 
concentration of GABA, edited measurements are usu-
ally relatively long (~10 minutes) and have a poor spatial 
resolution (~27 mL measurement volume). The most 
widely used implementation of editing is MEGA-PRESS 
(Mescher and others 1998).
It is a major limitation that edited MRS does not only 
edit GABA signals—the edited signal at 3 ppm contains 
contributions from other GABA-like metabolites such as 
homocarnosine and a substantial contribution from mac-
romolecules (MM). Co-editing of MM signal occurs 
because there is an MM signal at 1.7 ppm (close to the 
GABA signal at 1.9 ppm that editing pulses are applied 
to) that is coupled to an MM signal at 3 ppm (underneath 
the edited GABA signal). Thus, MM co-edits with 
GABA, and the edited GABA signal is usually referred to 
as GABA+. MM-suppressed editing schemes have been 
proposed to address this issue (Henry and others 2001), 
but they suffer from increased variance due to scanner 
instability and subject motion (Edden and others 2016).
J-difference editing with MEGA-PRESS is an inher-
ently wasteful technique, aimed at acquiring edited signal 
from just one metabolite (GABA) in one brain region at a 
time. The long duration of measurements makes this 
Figure 4. Improved learning performance after intermittent theta burst stimulation (iTBS) associated with modulation of 
parvalbumin (PV) expression. (A) Rats learned a tactile discrimination task in a radial maze significantly faster when treated with 
iTBS (red curve) compared with animals receiving continuous TBS (cTBS) (green) or sham stimulation (yellow). (B) The numbers 
of PV+ cells were strongly reduced in barrel and visual cortex (and other areas) if rats had been treated with iTBS but did not 
perform the task. However, PV expression increased after learning in task related areas (barrel, motor, frontal cortex) but not in 
visual cortex while cTBS had no significant effect. The figure has been redrawn on the basis of data published in Mix and others 
(2010).
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inefficiency particularly stark, and it is not uncommon for 
an hour-long MRI protocol to only make GABA measure-
ments from three brain regions. There is therefore strong 
interest in improving the acquisition efficiency (or tempo-
ral signal-to-noise ratio) of measurements by multiplexing 
editing of multiple metabolites and/or multiple regions.
Hadamard Encoding and Reconstruction of MEGA-
Edited Spectroscopy (HERMES) performs MEGA-edited 
measurements of more than one metabolite at the same 
time, by using orthogonally applied editing timings for 
each metabolite (Chan and others 2016). For example, 
whereas the GABA-encoding across averages might be 
ON-OFF-ON-OFF . . ., an alternative editing target 
(Harris and others 2017) such as glutathione (GSH) might 
be encoded as ON-ON-OFF-OFF. Thus, the GABA-OFF 
scans can be subtracted from the GABA-ON scans to 
give the GABA-edited spectrum and the GSH-OFF scans 
can be subtracted from the GSH-ON scans to give the 
GSH-edited spectrum without compromise of the editing 
selectivity (Saleh and others 2016). Simultaneous editing 
of GABA in more than one voxel has also been imple-
mented using parallel reconstruction (Oeltzschner and 
others 2017) and spatially selective Hadamard editing 
(Chan and others 2017). The ability to acquire more 
information within the same amount of time will change 
the types of studies that can be planned in the future, and 
allows for the investigation of relationships within and 
between biochemical systems.
Figure 5. Drug-induced modulation of transcranial magnetic stimulation (TMS)–evoked electroencephalographic (EEG) 
potentials (TEPs). (A) TEPs elicited by TMS over the primary motor cortex were recorded before (pre, blue) and after (post, 
red) intake of a single oral dose of alprazolam (1 mg), zolpidem (10 mg), or placebo; (B) before (pre, blue) and after (post, red) 
intake of a single oral dose of diazepam (20 mg), baclofen (50 mg), or placebo. While alprazolam increased the N45 and reduced 
the N100 amplitude, zolpidem increased the N45 only. Diazepam increased the N45 and reduced the N100 similar to alprazolam, 
whereas baclofen increased the N100. Modified from Premoli and others (2014), with permission. (C) A single oral dose of 100 
mg, but not 50 mg of S44819, a selective GABAAα5R antagonist, reduced the N45 amplitude (comparison between before [pre, 
blue] and after [post, red] drug intake). Modified from Darmani and others (2016), with permission. Horizontal bars underneath 
TEPs denote significant periods of drug-induced changes. Shades represent ±1 SEM.
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Figure 6. GABA difference editing using MEGA-PRESS. (A) 
GABA has signals at 1.9, 2.3, and 3 ppm, which are masked by 
larger concentration metabolites such as N-acetyl aspartate 
(NAA), creatine, and choline, and is therefore not visible in 
a typical unedited magnetic resonance (MR) spectrum at 3 
T. In MEGA-PRESS, during the Edit-OFF condition, editing 
pulses are placed off resonance, and signals evolve as normal. 
In the Edit-ON condition however, editing pulses are placed 
at 1.9 ppm, selectively affecting the GABA signal at 3 ppm 
(masked by the larger creatine signal) and suppressing the 
NAA signal. As the creatine and choline signals were not 
affected in either condition, but GABA was, the difference 
spectrum (DIFF) contains only those signals that were affected 
by the frequency selective editing pulse at 1.9 ppm. The 
creatine signal is edited out, and a quantifiable GABA signal is 
now visible at 3 ppm. Because of the low concentration, the 
edit-OFF and edit-ON conditions are typically repeated 160 
times to obtain sufficient signal to noise. (B) Sensorimotor 
GABA levels correlate negatively with tactile frequency 
discrimination in healthy adults and children (8-12 years 
old; inset), showing that participants with more GABA are 
better at the task. This is reflective of other work showing 
that GABA levels in a region related to a certain behavioral 
function are correlated with performance in that behavior in 
healthy participants. Data were presented in Puts and others 
(2011) and Puts and others (2017).
Figure 6. (continued)
Magnetic Resonance Spectroscopy of 
GABA and Cognition
GABA plays an important role in regulating brain activity 
and shaping the neuronal responses to incoming sensory 
input. As such, GABA is also critically involved in encod-
ing sensory information. Using MRS of GABA, it has 
been shown that individual differences in occipital GABA 
levels are correlated with healthy participants’ ability to 
discriminate visual orientation, linking known animal 
work to human perception (Duncan and others 2014). 
Similarly, sensorimotor GABA levels were correlated 
with healthy participants’ ability to discriminate tactile 
frequencies (Duncan and others 2014; Puts and others 
2011), a finding later replicated in typically developing 
children, but not in children with neurodevelopmental 
disorders (Puts and others 2017) (Fig. 6B).
Several other studies have shown links between GABA 
and cognition, including studies linking dorsolateral pre-
frontal cortex GABA to working memory (Duncan and 
others 2014; Yoon and others 2016) and impulsivity (Boy 
and others 2011; Yoon and others 2016), and supplemen-
tary motor area GABA levels to motor distraction (Duncan 
and others 2014; Mullins and others 2014). Other studies 
have found that GABA levels change with age, and reduc-
tions in GABA with age have been linked to alterations in 
cognitive processing (Harris and others 2017; Porges and 
others 2017). One key observation across these various 
studies is that MRS measurements of GABA are region-
ally and functionally specific. Furthermore, interindivid-
ual differences in baseline GABA levels from a region 
relevant to a certain task can predict behavioral perfor-
mance on that task. Interestingly, and perhaps surpris-
ingly, these macro-level findings often reflect animal/
cellular metrics of GABA function, providing a link 
between micro-level biochemistry and macro-level behav-
ioral function (Duncan and others 2014).
While the aforementioned studies focus on baseline 
GABA levels—that is, GABA levels measured at rest—
other studies have investigated GABA under conditions of 
plasticity. In one of the first studies applying MRS of 
GABA, it could be shown that during an ischemic block, 
motor cortex (M1) GABA levels significantly decreased as 
a function of time, reverting after ischemic block was 
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released, possibly reflecting a release of inhibition to allow 
for plastic changes to take place (Levy and others 2002). 
Floyer-lea and colleagues (2006) showed that M1 GABA 
levels decrease during a motor learning task. In several 
studies, it has been shown that GABA levels can be altered 
using non-invasive brain stimulation; concurrent TMS 
over M1 increases GABA levels, whereas both anodal and 
cathodal transcranial direct current stimulation reduces 
GABA levels (Stagg 2014). Finally, it could be demon-
strated that baseline GABA levels in the sensorimotor cor-
tex (preintervention) predicted performance improvement 
on a two-point discrimination task after repetitive electrical 
stimulation of the fingers, interestingly individual GABA 
levels changed in a homeostatic manner rather than on a 
group-average level (Heba and others 2016).
There is an increasing interest in studying GABA lev-
els in disease (Puts and Edden 2012), for example, in neu-
rodevelopmental disorders, neurodegenerative diseases 
and chronic pain. Previous work has suggested altered 
GABAergic function in autism spectrum disorder (ASD), 
attention deficit hyperactivity disorder (ADHD), and 
Tourette syndrome (TS). MRS studies of GABA in these 
disorders corroborate this previous work, showing 
reduced GABA levels in children with ASD and ADHD 
(for reviews, see Ford and Crewther 2016; Schür and oth-
ers 2016) although this may be region-dependent (occipi-
tal GABA appears unaffected in ASD). Although altered 
GABA has been shown in TS (Draper and others 2014; 
Freed and others 2016; Puts and others 2015), the work is 
inconsistent, with some studies showing increased and 
others decreased GABA levels. These differences might 
be related to regional cortical differences, cohorts stud-
ied, or methodological considerations, and are perhaps 
more difficult to interpret.
Linking MRS to brain function and cognition has limi-
tations. Associations between GABA levels and cognitive 
and behavioral measurements at rest or after learning, that 
are present in healthy participants, are not always easy to 
interpret and may not be present in disease. Interpretation 
of the functional relevance of the presence, or absence of 
these associations is often based on links with cellular and 
animal work. Further studies are necessary to determine 
the link between MRS of GABA and inhibitory processing 
on a mechanistic level, which may be particularly relevant 
for studying the GABA system in disease. Furthermore, 
findings are not always replicated (Cousijn and others 
2014; Harris and others 2015), limiting the reproducibility 
and interpretability of these studies and are likely due to 
experimental and biological effects, such as small cohort 
size and differences in cohorts. In summary, MRS of 
GABA allows for functionally relevant in vivo measure-
ments of the role that GABA plays in driving behavior and 
cognition in health and disease, and is an important contri-
bution to the study of GABA in health and disease.
Neurochemical Imaging of Chronic 
Pain
Over the past 15 years, the application of MRS in the 
investigation of chronic pain has gained traction and 
recent studies have suggested that GABA and glutamate 
are strong correlates of the subjective pain experience. In 
healthy participants, thalamic GLX (combined glutamate 
and glutamine) levels predicted pain thresholds 
(Zunhammer and others 2016). MRS has also been applied 
to study GABA and GLX levels in patients with chronic 
pain. GLX levels have been shown to be elevated in fibro-
myalgia patients within the posterior insula (Harris and 
others 2009). Elevated GLX levels were associated with 
evoked pain sensitivity, suggesting that glutamatergic 
activity in this region of the brain might be in part respon-
sible for the “gain setting” on central neural pain process-
ing. In a longitudinal trial of acupuncture and sham 
acupuncture, it could be demonstrated that changes in 
GLX levels, specifically within the posterior insula cor-
tex, tracked with changes in both experimental and clini-
cal pain (Harris and others 2008). In that study, reductions 
in GLX were associated with greater improvements in 
both clinical and experimental pain. Importantly, changes 
in insular GLX were also associated with concomitant 
changes in the brain’s functional response to evoked pres-
sure pain during fMRI, suggesting that brain GLX levels 
may be associated with neuronal activity. As such 
increased GLX levels could enhance excitatory neuro-
transmission and subsequent pain. Interestingly increased 
GLX levels have been reported in animal models and have 
been proposed in fibromyalgia (Zhuo 2008). On the other 
hand, GABA levels were shown to be reduced in fibromy-
algia patients within the anterior insula but not in the pos-
terior insula (Foerster and others 2012) (Fig. 7A and B).
Importantly, lower GABA levels within the posterior 
insula were associated with greater pain sensitivity. In 
patients with chronic neuropathic pain after spinal cord 
injury GABA levels within the thalamus were shown to 
be decreased as compared with healthy controls and 
patients after spinal cord injury, but without pain (Gustin 
and others 2014), suggesting that thalamic disinhibition 
might play a role in the genesis of neuropathic pain. In 
patients with osteoarthritis pain, it was inversely corre-
lated with GABA in the anterior cingulate cortex 
(Reckziegel and others 2016). In aggregate, these find-
ings suggest a neurotransmitter imbalance within regions 
critically involved in pain processing, in terms of 
increased glutamate and decreased GABA levels. 
Pharmacologic studies using neurochemical imaging 
derived outcomes have also been reported in chronic 
pain. Preclinical work with pregabalin, an efficacious 
drug for fibromyalgia, suggested that the mechanism of 
action of this compound was to reduce the release of 
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glutamate into the synaptic cleft (Micheva and others 
2006). Of note, an MRS study found that pregabalin 
reduced GLX levels in the posterior insula and higher 
pretreatment levels of GLX in this region were associated 
with greater subsequent reductions in experimental pres-
sure pain sensitivity (Harris and others 2013).
Future studies in chronic pain will need to better link 
neuroplastic brain changes with both pain and nonpain 
clinically relevant outcomes. Many chronic pain patients 
report fatigue, cognitive deficits, mood disturbance, and 
poor sleep and these outcomes should also be explored 
with MRS.
Conclusion
In this review article, we sought to bring together some 
important aspects of the role and function of the main 
inhibitory neurotransmitter GABA from researchers in 
different sub-fields, working at different levels of neural 
organization and using different methods to investigate 
GABAergic systems, that is, tetrode recordings, TMS, 
EPs, EEG, and MRS. Linking the function of specific cell 
populations and/or neurotransmitter systems to percep-
tion, cognition and behavior is one of the main goals and 
at the same time greatest challenges of modern neurosci-
ence. Different methods reveal different aspects of what 
we hypothesize to be the same system, yet on different 
scales of complexity and spatial resolution. Scientific 
progress very much depends on the range and accuracy of 
the methods applied, and methodological specialization 
allows for a high degree of focus within specific subfields. 
The downside of specialization is that scientists with a 
common interest, for example, on GABA neuroscience, 
yet from different backgrounds, risk losing (or not even 
establishing) contact. As such the distinction between dif-
ferent subtypes of GABAergic interneurons is currently of 
little relevance to MR spectroscopists. Likewise, the poor 
resolution of GABA spectroscopy combined with the lack 
of site specificity (intracellular, extracellular, etc.) leaves 
the basic scientist somewhat puzzled.
Among researchers (methodological) reductionism 
stating that entire systems can be explained in terms of 
their constituent parts and their interactions is common. 
As such there is the basic assumption that findings in 
single cells and small cell assemblies translate not only 
into local but also into far-ranging, large-scale networks, 
which finally help to explain higher cognitive functions. 
It is an epistemological, rather than a scientific question 
as to what actually defines complexity, for example, the 
number of neurons and their interactions, the method 
applied and its outcome parameters, or the hypothesis to 
be verified (or falsified). As such the term complexity 
does not necessarily refer to the world per se, but to the 
way we formulate and address a specific question. It will 
be of critical importance to integrate results yielded by a 
specific method into a conceptual framework that is 
accessible by researchers from other subfields. In the case 
of GABA, one candidate topic to provide such a concep-
tual framework is oscillatory activity. In the mature brain, 
GABA strongly shapes cortical gamma and hippocampal 
theta oscillations. These oscillations have the potential to 
be the heuristic backbone to both link microcircuitry to 
larger networks, accessible to EEG, EP, and MRS, and 
also to link neurophysiology to behavior. Furthermore, 
computational neuroscience holds promise to generate 
common denominators and even models that have the 
potential to bridge these gaps. However, an approach that 
could be called “integrative neuroscience” is probably 
needed to fully understand how a four-carbon molecule 
shapes complex behavior.
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